Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Pain. 2017 Jun;158(6):1083–1090. doi: 10.1097/j.pain.0000000000000866

Table 1.

Patient-reported outcome measures included in COMPACT

Domain Outcome Measure Construct
Participant characteristics Gender, affected limb, limb dominance prior to CRPS, CRPS duration, participation in employment/education/voluntary work Demographic data
Pain Numeric Rating Scale and PROMIS 29 Profile (version 2)[13] Pain intensity: average, worst, least
Short-form McGill Pain Questionnaire SF-MPQ-2 [18] Six neuropathic pain items
PROMIS 29 Profile (version 2) [13] Pain interference.
EQ-5D-5L [32] Health state comprising mobility, self care, usual activities, pain/discomfort, anxiety/depression.
Disease severity CRPS Severity Score [30] Severity of CRPS
CRPS symptom questions Experience of CRPS
Participation and physical function. PROMIS 29 Profile (version 2) Physical function, social participation
EQ-5D- 5L See above
Emotional and psychological function PROMIS 29 Profile (version 2) Anxiety, depression, fatigue, sleep
PROMIS suicidal ideation question [45] Suicidal ideation
EQ-5D- 5L See above
Catastrophizing Pain Catastrophizing Scale [53] Pain catastrophizing
Self efficacy Pain Self-efficacy Questionnaire [40] Self-efficacy
Patient's global impression of change Patient Global Impression of Change# Change in CRPS from baseline
#

To be completed at T2 only